DES MOINES, Iowa, April 27, 2017 /PRNewswire/ -- Eurofins Food Safety Systems has achieved ISO 17021 accreditation for Food Safety Management Systems and Management Systems Certification from the Joint Accreditation System of Australia and New Zealand (JAS-ANZ).
The accomplishment designates Eurofins Food Safety Systems as a fully-accredited certification body able to perform certification audits to FSSC 22000, ISO 22000, and FAMI-QS standards around the globe. In October 2016, Eurofins achieved ISO 17065 accreditation for the scope of SQF V7.2.
"We care about providing our customers with impartial, unbiased assessments to improve food safety," said Gary Smith, Director of Eurofins Food Safety Systems. "By receiving accreditation, we ensure an added layer of protection and oversight to meet this goal."
JAS-ANZ accreditation is recognized and accepted around the world as the highest and most credible type of accreditation that a certification body can obtain. The group offers world renowned accreditation services for businesses, regulators and government.
Eurofins Food Safety Systems is recognized for its efforts and capabilities in the field of food safety audits. As a certification body, Eurofins conducts audits to food safety standards benchmarked to GFSI (Global Food Safety Initiative) including SQF, BRC, and FSSC 22000.
"We strive to provide value-added assessments to manufacturers on a global basis. Successfully maintaining ISO 17021 and ISO 17065 accreditations through JAS-ANZ validates Eurofins' competence and commitment to the highest level of quality," concluded Smith.
For more information, please visit www.eurofinsus.com/food-safety/certification.
Notes for the editor:
Eurofins Scientific believes it is the world leader in food, environment and pharmaceutical products testing, as well as one of the global market leaders in agroscience, genomics, discovery pharmacology and central laboratory services. In addition, Eurofins is one of the key emerging players in specialty clinical diagnostic testing in Europe and the USA.
With over 28,000 staff in more than 310 laboratories across 39 countries, Eurofins offers a portfolio of over 130,000 validated analytical methods for evaluating the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as for innovative clinical diagnostic. The Group provides its customers with high-quality services, accurate results on time and expert advice by its highly qualified staff.
Eurofins is committed to pursuing its dynamic growth strategy by expanding both its technology portfolio and its geographic reach. Through R&D and acquisitions, the Group draws on the latest developments in the field of biotechnology and analytical chemistry to offer its clients unique analytical solutions and the most comprehensive range of testing methods.
As one of the most innovative and quality oriented international players in its industry, Eurofins is ideally positioned to support its clients' increasingly stringent quality and safety standards and the expanding demands of regulatory authorities and healthcare practitioners around the world.
The shares of Eurofins Scientific are listed on the Euronext Paris Stock Exchange (ISIN FR0000038259, Reuters EUFI.PA, Bloomberg ERF FP).
Important disclaimer:
This press release contains forward-looking statements and estimates that involve risks and uncertainties. The forward-looking statements and estimates contained herein represent the judgment of Eurofins Scientific as of the date of this release. These forward-looking statements are not guarantees for future performance, and the forward-looking events discussed in this release may not occur. Eurofins Scientific disclaims any intent or obligation to update any of these forward-looking statements and estimates. All statements and estimates are made based on the data available to the Company as of the date of publication, but no guarantee can be made as to their validity.
SOURCE Eurofins
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article